NCT00359567View on ClinicalTrials.gov

Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

1,140

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

August 31, 2007

Conditions
Chemotherapy-Induced Nausea and Vomiting
Interventions
DRUG

palonosetron

intravenous injections of 0.75 mg palonosetron (5 mL) and then granisetron placebo before administration of highly emetogenic chemotherapy, concomitantly administered with corticosteroids.

DRUG

granisetron hydrochloride

intravenous injections of palonosetron placebo and then 40μg/kg granisetron hydrochloride before administration of highly emetogenic chemotherapy, concomitantly administered with corticosteroids.

Trial Locations (1)

104-0045

National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo

All Listed Sponsors
lead

Taiho Pharmaceutical Co., Ltd.

INDUSTRY

NCT00359567 - Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy | Biotech Hunter | Biotech Hunter